Cite
Arsenic Trioxide Synergistically Enhances the Antileukemia Activity of Bcl-2 Inhibitor ABT-199 in Acute Myeloid Leukemia
MLA
Sha Liu, et al. “Arsenic Trioxide Synergistically Enhances the Antileukemia Activity of Bcl-2 Inhibitor ABT-199 in Acute Myeloid Leukemia.” Blood, vol. 134, Nov. 2019, p. 2555. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........2c29d7ba772993e3e47e71d874483c3a&authtype=sso&custid=ns315887.
APA
Sha Liu, Ruihua Mi, Lin Chen, Xiaojiao Wang, Ruihua Fan, Xudong Wei, & Qingsong Yin. (2019). Arsenic Trioxide Synergistically Enhances the Antileukemia Activity of Bcl-2 Inhibitor ABT-199 in Acute Myeloid Leukemia. Blood, 134, 2555.
Chicago
Sha Liu, Ruihua Mi, Lin Chen, Xiaojiao Wang, Ruihua Fan, Xudong Wei, and Qingsong Yin. 2019. “Arsenic Trioxide Synergistically Enhances the Antileukemia Activity of Bcl-2 Inhibitor ABT-199 in Acute Myeloid Leukemia.” Blood 134 (November): 2555. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........2c29d7ba772993e3e47e71d874483c3a&authtype=sso&custid=ns315887.